UBXN11 and immune system disorder: Amongst SOC categories with > 10 drug-AE pairs, the proportion of serious reports of immune system disorders was the highest in Asia (63.9% of all reports were serious reports), whereas cardiac disorders were highest in Europe (46.7% of all reports were serious reports) (Table 2).